In vitro study reveals that Eucalyptus gunnii extracts inhibit and disaggregate alpha-synuclein amyloid fibrils, highlighting natural compounds for neurodegenerative disease therapy.
Key Points
Extracts from Eucalyptus gunnii effectively inhibit amyloid formation and disassemble preformed alpha-synuclein amyloid fibrils in vitro without causing observable cell damage.
In vitro evaluation identified miquelianin in the extract, demonstrating moderate inhibitory activity against amyloid formation relative to strong inhibitors quercetin and ellagic acid.
Findings support miquelianin as a mechanistic probe for alpha-synuclein assembly in the brain, though in vitro cell-free findings require validation in animal models.